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Abstract
Background: This study aimed to explore the value of extended motor nerve conduction studies
in patients with ulnar nerve entrapment at the elbow (UNE) in order to find the most sensitive and
least time-consuming method. We wanted to evaluate the utility of examining both the sensory
branch from the fifth finger and the dorsal branch of the ulnar nerve. Further we intended to study
the clinical symptoms and findings, and a possible correlation between the neurophysiological
findings and pain.
Methods: The study was prospective, and 127 UNE patients who were selected consecutively
from the list of patients, had a clinical and electrodiagnostic examination. Data from the most
symptomatic arm were analysed and compared to the department's reference limits. Student's t -
test, chi-square tests and multiple regression models were used. Two-side p-values < 0.05 were
considered as significant.
Results: Ulnar paresthesias (96%) were more common than pain (60%). Reduced ulnar sensitivity
(86%) and muscle strength (48%) were the most common clinical findings. Adding a third
stimulation site in the elbow mid-sulcus for motor conduction velocity (MCV) to abductor digiti
minimi (ADM) increased the electrodiagnostic sensitivity from 80% to 96%. Additional recording
of ulnar MCV to the first dorsal interosseus muscle (FDI) increased the sensitivity from 96% to 98%.
The ulnar fifth finger and dorsal branch sensory studies were abnormal in 39% and 30% of patients,
respectively. Abnormal electromyography in FDI was found in 49% of the patients. Patients with
and without pain had generally similar conduction velocity parameter means.
Conclusion: We recommend three stimulation sites at the elbow for MCV to ADM. Recording
from FDI is not routinely indicated. Sensory studies and electromyography do not contribute much
to the sensitivity of the electrodiagnostic evaluation, but they are useful to document axonal
degeneration. Most conduction parameters are unrelated to the presence of pain.
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Ulnar nerve neuropathy at the elbow (UNE) was
described in 1922 by Buzzard [1] who had had personal
experience with UNE. In 1958 Feindel and Stratford [2]
called the condition "cubital tunnel syndrome" in order
to indicate that its cause was assumed to be a compression
at the humeroulnar arcade. However, lesions at the ulnar
groove account for most cases [3]. A standardized inci-
dence rate of 20.9 cases per 100 000 persons per year has
been found [4]. In 1956 Simpson [5] described a neuro-
physiological method for the diagnosis of UNE, and new
methods have often been proposed and discussed.
Extended protocols like inching, recording from multiple
muscles, and conduction block evaluation have been eval-
uated [6-8], but there is no general agreement about the
optimal diagnostic procedure.
The clinical diagnosis of UNE can be difficult, and pain
may or may not be present. Gilliat and Thomas [9] stated
that they never had seen abnormal ulnar nerve conduc-
tion in patients with complaints of pain or paresthesia but
without physical signs on clinical examination. Eisen [10]
on the other hand found reduced motor conduction
velocity (MCV) across sulcus in 10 of 56 patients with
clinically mild ulnar lesions. Indeed, the relationship
between pain and electrophysiological findings in UNE
has not been much studied.
The purpose of this study was to compare the sensitivity
of our standard neurophysiological method for the diag-
nosis of UNE to an extended protocol. We specifically
wanted to evaluate the use of a mid-sulcus stimulation site
over the ulnar nerve at the elbow, and to compare record-
ing from the abductor digiti minimi muscle (ADM) to
recording from the first dorsal interosseus muscle (FDI) in
order to find the most sensitive and least time-consuming
effective method. Further we wanted to evaluate the utility
of examining both the sensory branch from the fifth finger
and the dorsal branch of the ulnar nerve. Finally, we
intended to study if pain related to other clinical symp-
toms and findings could predict the neurophysiological
severity of ulnar neuropathy. In the present study we
reported that three stimulation sites in the elbow for MCV
to ADM was the most effective method.
Methods
Patients
The study was prospective, and 127 UNE patients were
selected consecutively from the list of patients examined
in our department from 2002 - 2008. The clinical and
electrodiagnostic examinations were performed once in
each patient. The clinical inclusion criteria were based on
the symptoms and neurological findings indicative of
ulnar nerve entrapment [11]. The electrodiagnostic inclu-
sion criterium was at least one abnormal neurophysiolog-
ical findings in the ulnar nerve when a standard protocol
was used, i.e. either reduced MCV across the ulnar groove
(10 cm segment: < 50 m/s), reduced ADM amplitude (<
4.3 mV), or sensory conduction velocity (SCV) (< 48 m/s)
and amplitude (< 2 μV), according to our department's
reference values (n = 116 nerves from 100 subjects (15
healthy hospital employees and 85 patients controls with-
out neurological signs or disease, i.e. discharged with a
symptoms diagnosis, mean age 42 years, range 14 - 78
years, mean height 169 cm, range 154 - 198 cm). Subjects
with normal neurophysiological results were not included
in the study regardless of their symptoms and neurologi-
cal findings. The extended neurophysiological examina-
tion protocol (see below) was unchanged for the study
period. The nerve conduction examinations were first per-
formed by a neurophysiology technician and then con-
trolled (and rechecked if necessary) by one of the four
attending physicians, who also performed the electromy-
ography (EMG).
Exclusion criteria included either clinical or electrodiag-
nostic evidence of ulnar nerve entrapment at the wrist,
cervical radiculopathy, polyneuropathy or significant sus-
picion of carpal tunnel syndrome (CTS) or another clini-
cal condition apart from UNE.
The mean age of the patients was 50.5 (range 22 - 89;
median 52) years, 42 (33%) women and 85 (67%) men.
The mean height of the patients was 175 (154 - 193, SD =
8.8) cm. The duration of UNE symptoms at presentation
varied from 1 - 576 (mean 24.2, median 7.8) months. Sev-
enty-four patients (58%) had left ulnar nerve symptoms,
26 (21%) had ulnar symptoms in the right side and 27
(21%) had symptoms from both ulnar nerves. Fifty-six
patients (44%, n = 125) had had no other diseases, 12
(9.4%) had had neck symptoms, 9 (7.1%) had diabetes, 6
(4.7%) had had lumbar spine symptoms, 5 (3.9%) had
had CTS, 5 (3.9%) had had heart disease, 4 (3.1%) had
increased blood pressure, 3 (2.4%) had had cancer and
the rest had or had had a variety of different diseases. Five
(3.9%) had experienced trauma to one elbow, 4 (3.1%)
had had epicondylitis, one used elbow crutches and one
had previously been operated for UNE.
Neurophysiological examinations
Motor and orthodromic sensory conduction studies of the
ulnar and median nerves were performed bilaterally. All
studies were performed with the Dantec Keypoint appara-
tus (Dantec Medical A/S, Skovlunde, Denmark), using
previously described methods [12,13]. The ulnar nerve
was stimulated at the wrist, 4 cm below the midpoint of
the ulnar sulcus in the elbow, in the sulcus, 6 cm above
the sulcus midpoint and 10 cm proximally in the axilla,
with surface recording electrodes over both the ADM and
FDI. The sensory ulnar nerves were stimulated with ringPage 2 of 8
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nerve action potential (SNAP) was recorded with surface
electrodes at the wrist. The dorsal sensory ulnar branch
was stimulated with a saddle electrode at the dorsum of
the hand and recorded at the wrist. Skin temperature was
measured and kept above 32°C [11] by means of heated
packs and a heating lamp. During the examination of the
ulnar nerve the arm was externally rotated at the shoulder
and the elbow flexed 70-90° [11,14,15]. Reference values
for the standard protocol, with 10 cm distance between
stimulation points in the elbow, were our department's
ordinary reference values (see above). Reference values for
the smaller segments (6 cm above and 4 cm below the
midpoint of the ulnar sulcus) were calculated from forty-
five non-symptomatic arms within the study group (28
men, 17 women, age 42 years, range 22-67 years) with
normal median and standard ulnar MCV and SCV. Only
patients with no disease (n = 38), migraine (n = 1), neck
pain (n = 4) and epicondylitis (n = 2), were accepted.
EMG with a concentric needle electrode was performed in
the FDI, and also in ADM and the abductor pollicis brevis
(APB) if relevant in selected patients. EMG was catego-
rized as "normal" or "neuropathic" according to our
standard EMG reference values.
Clinical neurological examinations
Paresthesias, numbness, pain in the elbow, forearm and
hand, and the feeling of reduced muscle power were
recorded. Sensitivity to pin-prick pain and light touch,
presence of muscle atrophy and reduced muscle strength
in the hands and arms were noted.
The research protocol was approved by the local institu-
tional review board and is in compliance with the Hel-
sinki Declaration. Patients received written information
about our nerve conduction study procedure before they
consented to come for the examination, and they were
also informed about the procedure on the day of the
examination by experienced technicians.
Statistical analysis
Amplitudes were log-transformed before the reference
limits were computed. In order to compensate for possi-
ble variation in the distribution between the parameters
we used the mean of three limits (mean - 2 SD, minimum
value (maximum value for latencies), and lower (upper
for latencies) 2.5% percentile.
In UNE patients, data from the most symptomatic arm
were analysed. In patients with bilateral symptoms and
bilateral conduction abnormalities, the right side was
chosen.
Conduction block was defined as at least 40% reduction
in amplitude at site 3 (in sulcus), 4 (above sulcus) or 5
(below axilla) compared to site 1 (wrist). The upper
amplitude reduction limit was 25% in the laboratory's ref-
erence limits and 33% in the present non-symptomatic
side reference sample.
Patients were grouped according to no pain versus pain in
the hand, forearm and elbow. CV parameters in sub-
groups were compared with Student's t - test. Frequencies
were compared with chi-square tests. The relation
between ulnar MCV and sensory amplitude (dependent
variables) and age, sex, height and symptom duration was
explored in multiple regression models. Two-side p-val-
ues < 0.05 were considered as significant. SYSTAT V.11
and SPSS v.15 statistical packages for Windows were used.
Results
In all cases of incomplete data set for different variables
the total number of examined patients are given.
Clinical symptoms
Ulnar paresthesias occurred in 117 of 122 patients (96%)
and subjectively reduced ulnar sensitivity occurred in 98
of 121 patients (81%). Altogether 72 of 120 patients
(60%) had pain. Elbow pain (50 patients, 41%) was
reported somewhat more frequently than hand (42
patients, 36%) and forearm (33 patients, 28%) pain.
Sixty-four of 120 (53%) reported reduced muscle strength
in the hand.
Clinical neurological findings
are shown in Table 1.
Neurophysiological findings
The MCV parameters for ADM and FDI in the most symp-
tomatic arm in all patients are displayed in Table 2. The
table show that with two stimulation points the across
sulcus segment were abnormal in 80% of the patients
which give 80% sensitivity for the old protocol. The sensi-
tivities for MCV at the different elbow segments are very
generally similar for ADM and FDI. For the corresponding
amplitudes the sensitivities were generally higher for FDI.
Recording from ADM we found reduced MCV in 68 arms
below sulcus ulnaris (4 cm segment, mean MCV = 33 m/
s) and in 87 arms above sulcus (6 cm segment, mean MCV
= 36 m/s). Thirty-three subjects had abnormal MCV both
above and below sulcus. From these numbers can be cal-
culated that 96% of the patients had abnormal MCV with
the new protocol with three stimulation points in the
elbow, which give a sensitivity of 96%. The sensitivity
increased with 16% by adding a third stimulation point in
the elbow. MCV across the elbow (over both segments: 10
cm) was abnormal in 102 of 127 subjects with mean MCV
= 38 m/s. Twenty patients with normal MCV across the
elbow had abnormal fractionated MCV either below orPage 3 of 8
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block (amplitude decrement > 40% at or above the
elbow) in 33 patients. Sixty-five percent of those with
block had ulnar motor weakness and/or atrophy on clini-
cal examination compared to 40% of those without block
(p = 0.005, chi-square test). Blocking was not related to
symptom duration (mean 23.3 month versus 25 months,
p = 0.9). Only two nerves with normal across-sulcus MCV
to ADM had block, but both had abnormal MCV either
below or above sulcus. Forty-four (35%) patients had
electrodiagnostic entrapment of the ulnar nerve at ADM
in both elbows.
With recording electrodes over the FDI muscle, we found
MCV abnormalities below, above and across sulcus in 51,
79 and 107 subjects (only 17 nerves were abnormal both
over and below sulcus). Only three subjects (2%) with
normal MVC over ADM across, below and above sulcus
had abnormal MCV recorded over FDI. Five subjects (4%)
with abnormal MCV over ADM across, below and above
sulcus had normal MCV recorded over FDI.
The results from the ulnar sensory nerve parameters are
seen in Table 3.
The amplitude of the sensory nerve from the fifth finger
was absent in 13, reduced in 31 and normal in 83 (65%)
patients. The dorsal ulnar nerve action potential was
absent in 18, reduced in 15 and normal in 91 (73%)
patients. Either amplitude or SCV was abnormal in 39%
and 30% respectively. In eleven patients with normal sen-
sory findings in the fifth finger we found abnormal dorsal
branch SCV or amplitude abnormality. In only one
patient with normal MCV over, under and across sulcus
(ADM) we found abnormal dorsal ulnar sensory ampli-
tude.
The results from the median nerves were used only for dif-
ferential diagnosis. All together 29 patients had slightly
abnormal distal motor velocity (APB) or SCV (third finger
or vola) on one or both sides compatible with non-symp-
tomatic CTS.
Patients with and without pain had generally similar CV
parameter means. F-responses were slightly longer (26.7
versus 25.7, Student's t-test, p = 0.02) and MCV was
decreased above sulcus in those without pain (40.2 versus
45.9 m/s, p = 0.028). Pain was not related to abnormality
rates for motor (ADM or FDI) or sensory (fifth finger or
dorsal branch) ulnar conduction, apart from less conduc-
tion block in those with pain (32%) compared to those
without pain (50%, p = 0.047, chi-square test). Pain was
not correlated with paresthesia, reduced sensitivity,
reduced ulnar strength or ulnar muscle atrophy (chi.-
square p > 0.18).
EMG was recorded from FDI in 124 patients (49% abnor-
mal). Abnormal EMG in FDI was found in 54% of 24
patients with abnormal standard MCV across the elbow,
and in 29% of 100 patients with normal MCV (chi-square
p = 0.03). Abnormal EMG in FDI was found in 52% of
those with pain and in 42% of patients without pain, a
non-significant difference (chi-square test, p = 0.26). EMG
was recorded from ADM in 40 patients (53% abnormal),
Table 1: The clinical findings in 127 UNE patients (mean age 50.5 years, median 52, range 22 - 89)
Clinical findings Patients with clinical findings Percent Number of patients1
Ulnar muscle atrophy 29 23.2 125
Median muscle atrophy 1 0.8 125
Radial muscle atrophy 0 0 125
Reduced ulnar muscle strength 59 47.6 124
Reduced median muscle strength 0 0 124
Reduced radial muscle strength 0 0 123
Reduced ulnar sensitivity in the hand 107 86.3 124
Other reduced sensitivity in the hand 6 4.7 124
Reduced D-M sens. in the forearm 16 12.9 124
D-M sens., reduced sensitivity distal and medial. The reduced ulnar muscle strength was weakness in finger spreading, abduction of the fifth finger 
and flexion of the fourth and fifth fingers. 1The numbers are less than 127 because information was missing in 2 - 4 patients.Page 4 of 8
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ings.
Discussion
Electrodiagnosis
The results from the electrodiagnostic (ED) studies
showed that 16% of patients with electroclinical UNE
were not diagnosed by the use of only two stimulation
sites below and above the ulnar groove. Consequently, we
will advocate three stimulation sites in the elbow. Smaller
distances in segmental nerve conduction studies are prob-
ably safe with modern electrodiagnostic equipment [16].
Recording from ADM and FDI gave very much the same
results, as shown in Table 2[17-19]. Conduction velocity
in the forearm while recording from ADM was abnormal
in 21% of the patients, most probably caused by pro-
nounced axonal degeneration in the nerve. We found a
significant correlation between no pain in the elbow and
decreased MCV above sulcus, which may indicate that
entrapment in the ulnar groove is less painful than in the
cubital tunnel. Blocking of thin myelinated A-delta fibres
can explain this association. A general lack of correlation
between pain and ED is not unexpected as thin-fibres
function is not reflected in CV parameters. However, we
could not confirm that patients with pain should be less
likely to show abnormal CV for the majority of parame-
ters.
Fibres to FDI may be more susceptible to demyelination
compared to fibres to ADM [20]. However, only 2.3% of
the patients had normal results in the ADM recording and
abnormal findings in the FDI recording. The most cost-
effective procedure is consequently to use only ADM
recordings, with optional recording over FDI, and addi-
tional use of the inching technique [6,8] in selected cases.
The advantages of the new protocol are that it can be per-
formed as a screening test by the neurophysiology techni-
cians. There is less risk of electrical spreading due to longer
Table 2: The ulnar motor nerve parameters in 127 UNE patients (most symptomatic arm)
Motor parameters Abductor digiti minimi muscle First dorsal interosseus
Mean (sd) Range % abnormal (ref.lim) Mean (sd) Range % abnormal (ref.lim)
Distal latency (ms) 3.0 (0.4) (2.2-4.6) 7% (3.6) 3.6 (0.5) (2.3-5.3) 6% (4.4)
Forearm MCV (m/s) 56 (6) (36-71) 21% (52) 55 (6) (32-70) 17% (51)
Below sulcus (m/s) 45 (16) (13-67) 54% (49) 45 (14) (9-67) 40% (44)
Above sulcus (m/s) 44 (14) (10-70) 69% (48) 42 (14) (10-75) 62% (45)
Across sulcus (m/s) 41 (9) (11-67) 80% (49) 40 (8) (10-59) 84% (48)
Upper arm (m/s) 62 (7)* (35-77) 6% (51) 62 (7)† (33-77) 7% (51)
F-M (ms) 26.1 (2.3) (19.0-33.6) 31% (27.3)
Wrist amplitude (mV) 8.2 (2.4) (1.0-14.0) 16% (6.3) 8.7 (3.8) (0.2-18.2) 33% (7.3)
Below sulcus (mV) 7.3 (2.5) (1.0-13.1) 20% (5.1) 7.3 (3.7) (0.1-17.3) 28% (5.1)
In sulcus (mV) 6.8 (2.6) (0.9-12.9) 25% (5.3) 6.7 (3.5) (0.1-17.1) 33% (5.2)
Above sulcus (mV) 6.0 (2.6) (0.4-12.7) 35% (5.2) 5.8 (3.4) (0.1-14.7) 44% (5.1)
Upper arm (mV) 5.9 (2.6)‡ (0.4-11.7) 34% (5.0) 5.7 (3.4) (0.0-14.4) 56% (6.0)
Relative amplitude 0.70 (0.24) (0.07-1.36) 30% (0.67) 0.64 (0.27) (0.00-1.10) 34% (0.58)
*Co-stimulation of the ulnar and the median nerve in 5 patients and not used; †Co-stimulation of the ulnar
and the median nerve in 13 patients and not used; ‡Not recorded in one patient.Page 5 of 8
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four cm), while the segment steps in the inching tech-
nique are one or two cm. However, this study did not aim
to compare the new protocol and the well known inching
technique. Inching is also a superior technique in experi-
enced hands for precise localization of ulnar nerve entrap-
ment at the elbow.
Significant conduction block (amplitude decrement >
40%) at the elbow were found in 26% of the patients. This
is a definite sign of nerve entrapment, but it was a rather
infrequent finding in this UNE study, and it was not
related to symptom duration. In another study [21] of 244
UNE patients 16% had motor conduction block (ampli-
tude decrement ≥ 50).
The sensory nerve from the fifth finger was abnormal in
39% of the patients, and 30% had an abnormal dorsal
ulnar nerve study. These results are in contrast to the large
prevalence of sensory symptoms as 96% reported ulnar
paresthesias and 86% had objectively reduced ulnar sen-
sitivity in the hands. This discrepancy can be explained by
a selection bias because patients with more severe symp-
toms and signs tend to be admitted for electrodiagnostic
studies. The ulnar sensory findings in UNE patients in
other studies vary from zero abnormal distal findings [6]
to 51 - 55% abnormal sensory studies across the elbow
[7,22]. However, even if sensory studies do not contribute
much to the sensitivity of the electrodiagnostic evalua-
tion, they are useful to document axonal degeneration or
severe dispersion within sensory fascicles.
We found abnormal EMG in about 50 percent of the UNE
patients and abnormal MCV (as opposed to conduction
block) was moderately associated with an increased rate
of neuropathic EMG. Bhala [23] found abnormal EMG in
78 percent of patients with reduced NCV < 45 m/s) across
the elbow with the highest abnormality rate in FDI. How-
ever, in our study only 31% of the UNE patients had EMG
from ADM (53% abnormal), while 98% had EMG from
FDI (49% abnormal). A more balanced examination rate
might have changed these figures.
Clinical findings and previous diseases
Ninety-six percent of the UNE patients reported paresthe-
sias in the ulnar territory, 86% had objectively reduced
ulnar sensitivity in the hand, 48% had reduced ulnar mus-
cle strength and 41% had pain in the elbow. Similar find-
ings occurred among patients who had 290 surgical
procedures for UNE [24]. In only 6% of our patients we
found reduced skin sensitivity outside the ulnar territory
in the hand and 16% reported reduced sensitivity distal/
medial in the forearm, which may be caused by a different
anatomical nerve distribution or an unspecific pain-
related dysfunction, as there were no clinical or electrodi-
agnostic evidence for another diagnosis in these patients.
According to the inclusion criteria only patients with
abnormal neurophysiological values of the ulnar nerve
were included. Suspected UNE patients with normal elec-
trodiagnostic values were consequently not included, and
the symptom distribution and neurological findings
might have been different with other inclusion criteria.
The frequency of previous CTS (3.9%) [25] and diabetes
mellitus (7.1%) [26,27] were close to prevalences within
the general population. Unexpectedly, only 4% had had
trauma to the elbow. Ten percent had had neck symtoms,
which is very common in the Norwegian society. Conse-
quently, UNE in this study seemed to be a singular condi-
tion probably caused by injury of the nerve, statical flexed
position of the elbow, simple overuse of one arm, genetic
predisposition, or an inflammation or another local dis-
ease in the elbow region [1].
We found 79% subjectively affected left ulnar nerves and
only 21% affected right nerves. Left ulnar nerve domi-
nance in UNE is also found in other studies [19]. The right
hand is dominant in most people and logically one would
have expected the opposite, if ordinary work played a
major role in the pathogenesis, which is found in CTS
[28]. In this study UNE prevailed in men (67%), in con-
cert with other studies [4,19,24,29]. Matev [30] reported
that the ulnar nerve in men is more mobile and therefore
more sensitive to gliding impairment at the medial epi-
condyle.
Table 3: The ulnar sensory nerve parameters in 127 UNE patients (most symptomatic side)
Sensory parameters Mean (sd) Range % abnormal (ref.lim)
Finger 5 amplitude (uV) 3.3 (2.8) (0.0-13.7) 35% (1.7)
SCV finger 5 (m/s) 53.9 (6.4)* (37.0-71.0) 17% (47.3)
Dorsal branch amplitude (uV) 5.0 (4.7)† (0.0-23.0) 27% (2.0)
SCV dorsal branch (m/s) 57 (8)‡ (24-74) 6% (46.6)
*The potential was unelicitable (0 μV) in seven patients; †Not recorded in three patients; ‡The potential was unelicitable (0 μV) in 18 patientsPage 6 of 8
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Differential diagnosis involves many diseases concerning
the spinal cord, cervical roots and other peripheral entrap-
ment sites. Consequently, clinical findings and tests in our
opinion are not sufficient to make a qualified diagnosis of
UNE. In the literature most surgeons advocate electrodiag-
nosis for UNE [24], but others prefer clinical testing with-
out electrodiagnosis [31]. Especially before surgery one
should produce direct evidence for entrapment of the
ulnar nerve at the elbow and single out other possible eti-
ologies. Electrodiagnosis before surgery is also recom-
mended in order to have a valid baseline for further
studies on patients with residual symptoms after surgery.
Patients might be in doubt whether to have an operation
or not, and results from a nerve conduction study can help
him/her to decide. Nonoperative management can also be
successful, especially in patients with symptoms only
[32].
There is no useful clinical gold standard for the diagnosis
of UNE. Attempts to define gold standards based on oper-
ative success will also fail because peroperative complica-
tions, placebo effects and spontaneous remissions will
interfere. Appropriately performed nerve conduction
methods, used for more than 50 years, have proved to be
very reliable, and most experts consider a combination of
clinical and electroneurographic signs as a "gold stand-
ard" for the most common entrapments. Accordingly, we
chose to apply electroclinical diagnostic inclusion criteria
in the present study. The advantage is that the diagnostic
precision is optimized, as it is recommended for the diag-
nosis of UNE [11]. We could accordingly compare sensi-
tivities among the various extended parameters. However,
it should be noted that the comparison between standard
and extended parameters in the present study could have
been biased in favor of the standard parameters because
they were among the inclusion criteria.
In addition we did not study other groups and could
accordingly not estimate specificities of the extended elec-
trodiagnostic parameters. Inclusion of patients with a
clinical picture suggestive of UNE without neurophysio-
logical evidence of entrapment (using the standard proto-
col) would have enabled us to also estimate specificities.
However, it should be noted that interpretation of specif-
icity is somewhat ambiguous when a definite gold-stand-
ard does not exist. Indeed, it will be difficult to differ
between true and false positives in a population with
symptoms suggesting UNE. Accordingly, specificity
should also be calculated in a healthy control group and
preferably, in a group with different symptomatology, for
instance carpal tunnel syndrome. The lack of such control
groups is a weakness of the present study. Accordingly, we
recommend to perform such controlled studies, as well as
prospective studies, in order to estimate specificities for
our extended electrodiagnostic parameters in different
groups, as well as the prognostic value of the extended
parameters.
Conclusion
Three stimulation sites in the elbow for MCV to ADM
seems to be a useful and sufficiently sensitive method in
the diagnosis of UNE, while recording from FDI is not
routinely indicated. Sensory studies and electromyogra-
phy do not contribute much to the sensitivity of the elec-
trodiagnostic evaluation, but they are useful to document
axonal degeneration. Most conduction parameters are
unrelated to the presence of pain. We advocate the use of
a neurophysiological examination in the diagnosis of
UNE to single out other differential diagnoses, because
symptoms and findings in this condition are not uniform.
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